Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Conti

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Drugs in Context|June 15, 2018
Immunotherapy in renal cell carcinoma: latest evidence and clinical implicationsMatteo Santoni, Francesco Massari, Vincenzo Di Nunno, et al.
Oncology and Therapy|July 24, 2020
Gender Differences and Outcomes in Melanoma PatientsFrancesca Morgese, Caterina Sampaolesi, Mariangela Torniai, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 23, 2013
Transrectal ultrasound (TRUS) and TRUS-biopsy accuracy in potential candidates for PRIAS active surveillance protocolVito Lacetera, Andrea Benedetto Galosi, Ubaldo Cantoro, et al.
International Journal of Cancer|January 14, 2014
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Francesco Massari, et al.
Urologic Oncology|May 17, 2015
Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasisAlessandro Conti, Matteo Santoni, Valeria Sotte, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 3, 2015
Diagnostic-therapeutic pathway for small lesions of the testisGiulia Sbrollini, Daniele Mazzaferro, Asim Ettamimi, et al.
Biochimica Et Biophysica Acta|February 1, 2014
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinomaMatteo Santoni, Francesco Pantano, Consuelo Amantini, et al.
Future Oncology (London, England)|July 11, 2015
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinomaAlessandro Bittoni, Francesco Piva, Matteo Santoni, et al.
World Journal of Urology|December 24, 2015
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patientsAlessandro Conti, Matteo Santoni, Luciano Burattini, et al.
Targeted Oncology|January 31, 2015
The route to personalized medicine in bladder cancer: where do we stand?Francesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Drugs in Context|June 15, 2018
Immunotherapy in renal cell carcinoma: latest evidence and clinical implicationsMatteo Santoni, Francesco Massari, Vincenzo Di Nunno, et al.
Oncology and Therapy|July 24, 2020
Gender Differences and Outcomes in Melanoma PatientsFrancesca Morgese, Caterina Sampaolesi, Mariangela Torniai, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 23, 2013
Transrectal ultrasound (TRUS) and TRUS-biopsy accuracy in potential candidates for PRIAS active surveillance protocolVito Lacetera, Andrea Benedetto Galosi, Ubaldo Cantoro, et al.
International Journal of Cancer|January 14, 2014
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Francesco Massari, et al.
Urologic Oncology|May 17, 2015
Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasisAlessandro Conti, Matteo Santoni, Valeria Sotte, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 3, 2015
Diagnostic-therapeutic pathway for small lesions of the testisGiulia Sbrollini, Daniele Mazzaferro, Asim Ettamimi, et al.
Biochimica Et Biophysica Acta|February 1, 2014
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinomaMatteo Santoni, Francesco Pantano, Consuelo Amantini, et al.
Future Oncology (London, England)|July 11, 2015
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinomaAlessandro Bittoni, Francesco Piva, Matteo Santoni, et al.
World Journal of Urology|December 24, 2015
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patientsAlessandro Conti, Matteo Santoni, Luciano Burattini, et al.
Targeted Oncology|January 31, 2015
The route to personalized medicine in bladder cancer: where do we stand?Francesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
Pageof 8